The JV intends to construct a plant to manufacture non-penicillin and non-cephalosporin Rx drugs and other drugs that are categorised as over-the-counter (OTC) products in Russia. It has also been contemplated to transfer 100 per cent interest in the CJSC Olifen (engaged in production of pharmaceutical substances) being held by Diod to the JV company, subject to due diligence.
336
599
119
599
2219
4399
999
1900
1323
2680
10999
0
11088
0
21000
0
7988
15976
599
1280
399
789
3278
0
1399
0
11000
0
11220
18700